Efficacy and tolerability of the histone deacetylase inhibitor panobinostat in clinical practice

E-ISSN： 1099-1069|36|1|210-216

ISSN： 0278-0232

Source： Hematological Oncology (Electronic), Vol.36, Iss.1, 2018-02, pp. : 210-216

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Safety, Efficacy and Therapeutic Potential of Histone Deacetylase Inhibitors with Special Reference to Panobinostat in Gastrointestinal Tumors: A Review of Preclinical and Clinical Studies

Current Cancer Drug Targets, Vol. 18, Iss. 8, 2018-10 ,pp. : 720-736

Bentham Science Publishers

Access to resources Recommend Favorite

Histone deacetylase inhibitors in clinical development

By Rosato Roberto R Grant Steven

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 1, 2004-01 ,pp. : 21-38

Informa Healthcare

Access to resources Recommend Favorite

Tolerability and Efficacy of Intravenous Administration of Pantoprazole in Routine Clinical Practice

By Bosseckert H.

Clinical Drug Investigation, Vol. 19, Iss. 2, 2000-02 ,pp. : 103-109

Adis International

Access to resources Recommend Favorite

Efficacy and Tolerability of Reboxetine in Depressive Patients Treated in Routine Clinical Practice

By Thomas Messer

CNS Drugs, Vol. 19, Iss. 1, 2005-01 ,pp. : 43-54

Adis International

Access to resources Recommend Favorite

Application of Hematological Toxicity Modeling in Clinical Development of Abexinostat (S-78454, PCI-24781), A New Histone Deacetylase Inhibitor

By Chalret du Rieu Quentin Fouliard Sylvain Jacquet-Bescond Anne Robert Renata Kloos Ioana Depil Stéphane Chatelut Etienne Chenel Marylore

Pharmaceutical Research, Vol. 30, Iss. 10, 2013-10 ,pp. : 2640-2653

Springer Publishing Company

Access to resources Recommend Favorite